Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Nianxin Fang"'
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Due to the low efficiency of a single clinical feature or laboratory variable in the diagnosis of tuberculous pleural effusion (TBPE), the diagnosis of TBPE is still challenging. This study aimed to build a scoring diagnostic mode
Externí odkaz:
https://doaj.org/article/44d4dab5486648018652b9b514d7fd27
Autor:
Chengzhi Zhou, Yilin Yang, Xinqing Lin, Nianxin Fang, Likun Chen, Juhong Jiang, Haiyi Deng, Yu Deng, Minghui Wan, Guihuan Qiu, Ni Sun, Di Wu, Xiang Long, Changhao Zhong, Xiaohong Xie, Zhanhong Xie, Ming Liu, Ming Ouyang, Yinyin Qin, Francesco Petrella, Alfonso Fiorelli, Sara Bravaccini, Yuki Kataoka, Satoshi Watanabe, Taichiro Goto, Piergiorgio Solli, Hitoshi Igai, Yuichi Saito, Nikolaos Tsoukalas, Takeo Nakada, Shiyue Li, Rongchang Chen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundCheckpoint inhibitor–related pneumonitis (CIP) is a lethal immune-related adverse event. However, the development process of CIP, which may provide insight into more effective management, has not been extensively examined.MethodsWe conduc
Externí odkaz:
https://doaj.org/article/55d8fcbc06d446b1bcfde80d09759586
Publikováno v:
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background ID1 is associated with resistance to the first generation of EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC). However, the effect of ID1 expression on osimertinib resistance in EGFR T790M-positive
Externí odkaz:
https://doaj.org/article/59742de0d4b043dea5815c85079b69d2
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Objective To analyze the prognostic significance of the pretreatment platelet/lymphocyte ratio (PLR) for targeted therapy in patients with epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC). Methods We conducted a retr
Externí odkaz:
https://doaj.org/article/adae95ffa91b48599d8a2a4da4c5bcc3
Publikováno v:
Chinese Journal of Lung Cancer, Vol 12, Iss 10, Pp 1130-1131 (2009)
Externí odkaz:
https://doaj.org/article/125a293c6bb14e6ab91acb073a26b614
Autor:
Nianxin, Fang, Zhengdao, Lai, Ruhong, Xu, Panwen, Huang, Guansheng, Ye, Weibo, Lu, Weiliang, Mo, Ping, Zhang
Publikováno v:
Acta Haematologica. 145:505-516
Introduction: Venous thromboembolism (VTE) is a common cardiovascular disease. MicroRNAs (miRNAs) play a key role in VTE; however, the role of exosomal miRNAs in VTE remains unknown. Therefore, we aimed to identify key exosomal miRNAs and their poten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c926544e67516abf1edabaef62c1651
https://doi.org/10.1159/000524569
https://doi.org/10.1159/000524569
Background: Due to the low efficiency of single clinical feature or laboratory variable in the diagnosis of tuberculous pleural effusion (TBPE), The diagnosis of TBPE is still challenging. This study aimed to build an efficient scoring diagnostic mod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22321beb38609ebf39718c09b20835a4
https://doi.org/10.21203/rs.3.rs-957673/v1
https://doi.org/10.21203/rs.3.rs-957673/v1
Publikováno v:
BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-11 (2021)
Background ID1 is associated with resistance to the first generation of EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC). However, the effect of ID1 expression on osimertinib resistance in EGFR T790M-positive NSCLC is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::707131091b014cf0fd7e3d2d65d0a9c4
https://doi.org/10.1186/s12890-021-01540-4
https://doi.org/10.1186/s12890-021-01540-4
Objective To analyzed the effect of ID1 overexpression on osimertinib resistance to T790M positive non-small cell lung cancer (NSCLC). Methods We established drug resistant cell line H1975/OR from osimertinib sensitive cell line H1975. Protein altera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fedfeffdcd2e47ac155ba33b43f35a6e
https://doi.org/10.21203/rs.3.rs-122918/v1
https://doi.org/10.21203/rs.3.rs-122918/v1
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
The Journal of International Medical Research
The Journal of International Medical Research
Objective To analyze the prognostic significance of the pretreatment platelet/lymphocyte ratio (PLR) for targeted therapy in patients with epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer (NSCLC). Methods We conducted a retr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec57bcacae98e32d7a627a38413131c
https://doaj.org/article/adae95ffa91b48599d8a2a4da4c5bcc3
https://doaj.org/article/adae95ffa91b48599d8a2a4da4c5bcc3